SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SPDR S&P 500 ETF TRUST - SPDR S&P 500 ETF Trust

SPY is experiencing a notable overnight rally driven by renewed ceasefire hopes and de-escalation signals in the Middle East, leading to a sharp drop in oil prices. While bulls are celebrating the recovery of key technical levels, the community remains divided, with some traders warning of a potential trap before a heavy week of earnings and central bank decisions.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

Rigetti Computing is trending as investors react to new federal executive orders aimed at accelerating U.S. quantum technology leadership and secure data migration. The community is actively debating the stock's long-term potential versus concerns over high cash burn rates, recent insider selling, and the reliability of government-linked catalysts.

Venture Global, Inc. engages in the provision of United States liquefied natural gas sourced from resource rich North American natural gas basins. It operates through the following segments: Calcasieu Project, Plaquemines Project, CP2 Project, and Sales and shipping. The company was founded by Michael Sabel and Robert Pender in 2023 and is headquartered in Arlington, VA.

Venture Global Inc. - Ordinary Shares - Class A

Venture Global Inc

Venture Global is trending as investors react to a significant jump in liquefaction fees and strong Q2 earnings guidance amid persistent global supply disruptions caused by conflict in the Middle East. The community is actively discussing the stock's potential for significant growth as it expands its LNG export capacity, while also debating the impact of geopolitical volatility and market manipulation on its current valuation.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is experiencing significant downward pressure as market participants debate the sustainability of its heavy AI capital expenditure, high debt load, and reliance on OpenAI's long-term financial commitments. While some investors are viewing the current pullback as a deep-value opportunity buoyed by massive government contract wins and long-term AI infrastructure backlogs, the community remains divided and highly concerned about ongoing share dilution and the lack of communication from management.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is facing a pivotal week as investors await the upcoming FDA advisory committee meeting to review deramiocel for Duchenne muscular dystrophy. The community is heavily focused on whether the panel will recommend a broad label covering both cardiac and skeletal muscle function, with intense discussion surrounding the recent physician and patient advocacy efforts pushing for approval of this treatment.

Omeros Corp. operates as a biopharmaceutical company, which engages in the research, discovery, development, and commercialization of small-molecule and protein therapeutics targeting immunologic diseases. It also offers orphan indications targeting inflammation, coagulopathies, and disorders of the central nervous system. The company was founded by Gregory A. Demopulos and Pamela Pierce Palmer on June 16, 1994 and is headquartered in Seattle, WA.

Omeros Corporation

Omeros Corp

Omeros Corp is trending as investors react to a combination of uncertainty surrounding the commercial launch of Yartemlea and speculation regarding competitive data updates from AstraZeneca. While some in the community are expressing frustration over management communication and market volatility, others view the recent price action as a strategic entry point, highlighting upcoming catalysts such as J-code implementation and a re-examination process with the EMA.

ExxonMobil is an international oil and gas company, providing energy that helps underpin growing economies and improve living standards around the world. It uses innovation and technology to deliver energy to a growing world. The company explores for, produces, and sells crude oil, natural gas and petroleum products.

ExxonMobil Holdings Corp.

Exxon Mobil Corp

Exxon Mobil is currently a major focus for investors as the energy sector reacts to shifting geopolitical tensions in the Middle East and ongoing uncertainty regarding oil supply chains. The community is actively debating the impact of these developments on upstream earnings, share buyback programs, and the broader relative strength of energy stocks compared to the tech-heavy market.

Luckin Coffee, Inc. engages in providing food and beverage items, and operates coffee retail stores. It has a pioneered a technology-driven retail network to provide coffee and other products of high quality, high convenience and high affordability to customers. The company manages pick-up stores, relax stores, and delivery kitchens. It also offers tea, snacks, and light meals through its mobile application. The company was founded by Zhi Ya Qian, Fei Yang and Jin Yi Guo on June 16, 2017 and is headquartered in Xiamen, China.

Luckin Coffee Inc - ADR

Luckin Coffee is currently trending as shareholders digest mixed sentiment regarding the company's aggressive expansion and market competitiveness against local rivals, while eagerly awaiting clarity on a potential relisting and buyback execution. Community discourse remains polarized between long-term investors highlighting consistent store growth and international footprint expansion, and frustrated traders pointing to persistent price volatility and the stock's long-term performance on the OTC market.

Forte Biosciences, Inc. is a biopharmaceutical company, which engages in the provision of dermatology products and services. Its lead product includes FB-401, which is a live biotherapeutic for the treatment of inflammatory skin disease, including pediatric and adult patients with atopic dermatitis. The company was founded by Paul A. Wagner on May 3, 2017 and is headquartered in Dallas, TX.

Forte Biosciences Inc

Forte Biosciences is trending as investors react to a significant oversubscribed private placement, which has triggered extreme volatility and intense community speculation regarding potential dilution versus long-term growth. Traders are actively debating whether this movement represents a sustainable momentum breakout or a typical biotech pump-and-dump setup.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

TSLA is seeing heavy volatility as investors debate the impact of major capital expenditures on AI, robotics, and autonomy projects following a recent earnings miss. The community remains deeply polarized, with active discussion revolving around whether this represents a temporary pullback for long-term growth or a structural decline due to intense competition and shifting market narratives.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

MITQ Rallies 17% in the Past Month: Should You Buy the Stock?

Strategic acquisitions, expanding margins, and a growing premium cinema solutions portfolio position MiT to capitalize on a multi-year theater upgrade cycle.


MITQ's Q3 Loss Narrows Y/Y as DCS Audio Sales Gain Traction

MiT posts a narrower year-over-year loss per share and improved margins in fiscal Q3 as sales from its newly acquired DCS loudspeaker business offset softer seasonal project activity.


The Zacks Analyst Blog Highlights Oracle, Intuitive Surgical, Analog Devices and Moving iMage Technologies

Oracle, Intuitive Surgical and Analog Devices lead fresh research as cloud growth, robotic momentum and AI tailwinds battle margin and tariff risks.

Top Research Reports for Oracle, Intuitive Surgical & Analog Devices

Oracle faces cloud competition and earnings volatility, yet AI-driven infrastructure growth and strong cash flow aim to power its next phase.

MiT Stock Down 6% Despite Q2 Loss Narrowing Y/Y on DCS Buyout

MITQ posts a narrower year-over-year net loss in Q2 and 10% revenue growth, driven by higher-margin product sales and integration of the DCS loudspeaker line.

MITQ's Q1 Earnings Up Y/Y, Eyes Growth via DCS Audio Expansion

MiT posts improved margins and a swing to profitability in fiscal Q1. The DCS speaker line acquisition is now a key growth driver as the firm pushes into global cinema audio markets.

The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage

Broadcom, Johnson & Johnson, and Palantir headline Zacks' latest analyst picks, with AI growth, pharma innovation, and defense tech momentum driving their outlooks.

Top Analyst Reports for Broadcom, Johnson & Johnson and Palantir

Broadcom's AI surge, J&J's resilient growth, and Palantir's defense-driven momentum headline today's top analyst reports.

MITQ Q4 Loss Narrows Y/Y, Laser & LED Upgrades Aids

MiT incurred narrower year-over-year losses in fiscal Q4 with expense cuts and sees growth in cinema tech from laser projection and Direct View LED upgrades despite softer revenue.

The Zacks Analyst Blog Highlights Netflix, Mastercard, Shell and Moving iMage

Netflix, Mastercard, Shell, and microcap Moving iMage stand out in Zacks research, each showing unique strengths and risks in growth and market positioning.

This account has been verified as an official MITQ representative.

Verified Account

MITQ IR

Moving iMage Technologies, Inc. engages in the design, integration, installation, and distribution of proprietary and custom designed equipment. It focuses on offering single source solutions for cinema design, procurement, installation, and service to creative and production communities. The firm provides custom engineering, systems design, integration, installation, digital technology solutions and products for software enhancement and theatre management. Its products include MiT Pedestals, MiT Dimmers & LED Lighting, MiT Automation, MiT ADA Accessibility, and CineQC. The company was founded by Joe Delgado, Bevan Wright, Jerry van de Rydt, David Richards, Glenn H. Sherman, Phil Rafnson, and Thomas Lipiec in September 2003 and is headquartered in Fountain Valley, CA.

Moving iMage Technologies Inc.

Bearish Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$0.51
Prev Close	$0.53
Open	$0.543
Dividend Yield	0.00%
50-Day Moving Average	$0.5926
Beta	0.91
Avg. Volume	63,856.54
PE Ratio	-29.48

52-Week High	$1.66
52-Week Low	$0.4201
Market Capitalization	$5.07M
EPS (Annual)	-$0.0957
Price to Book	1.04
Revenue Per Employee	$725,880.00

Feed

News

Sentiment

Earnings

Fundamentals

Info

MITQMoving iMage Technologies Inc.

Latest MITQ News